Tao Wu

Global Epidemiology, Office of Chief Medical Officer, Johnson & Johnson, China, China (People's Republic)

Poster(s):

• (300) Antipsychotics in treatment of adolescents with schizophrenia in China
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (306) Development of matching procedures to identify comparators for real-world comparative evaluations of antipsychotics
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (CSPOT05) Effect of long-acting injectable antipsychotics on treatment adherence and healthcare utilization in Chinese patients with schizophrenia: 1-year mirror-image study
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST